- Research and Projects
- Get Involved
Having a high blood platelet count is a strong predictor of cancer and should be urgently investigated to save lives, according to a large-scale study led by the University of Exeter Medical School and supported by PenCLAHRC.
Around two per cent of people over 40 – up to half a million people in the UK – have a raised blood platelet count, known as thrombocytosis.
Now, a study of 40,000 patient records has found that more than 11% of men and 6% of women over the age of 40 with thrombocytosis, went on to be diagnosed with cancer within a year. This rose...Read more
A team of researchers, including members of PenCLAHRC, have received £240,880 of funding from the NIHR Health Technology Assessment programme (NIHR HTA) for a new project looking to understand the efficacy, cost-effectiveness and current use of cancer diagnostic tools to aid decision-making in primary care.
For many types of cancer, survival is lower in the UK than for most European countries. Diagnostic tools that can predict the risk of cancer in patients with symptoms have been developed and are available for GPs to use in clinical practice. However, there are no summaries of the evidence on whether using these tools improves...Read more
The incidence of prostate cancer among men of Afro-Caribbean origin is higher than in white men, they are more likely to be diagnosed as emergencies and their mortality rates are higher. Until now it has been unclear why these disappointing outcomes exist.
To investigate the possible effects of patients’ preferences and choices, a team led by the University of Exeter Medical School, and supported by PenCLAHRC, carried out a study in more than 500 men attending general practices in Bristol.
The men were presented with realistic hypothetical scenarios - each included a description of a prostate cancer symptom and the estimated risk of prostate...Read more